Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to apply a novel advanced magnetic resonance imaging methodology to evaluate the response to drug intervention involving two treatment arms of postmenopausal participants with osteoporosis, randomized into either a teriparatide (Forteo™) or zoledronic acid (Reclast™) group.


Clinical Trial Description

The overall design is to determine and compare the effect of teriparatide and of zoledronic acid on trabecular architecture by magnetic resonance imaging of the midshaft tibia. Post-menopausal women, aged 60 or older with osteoporosis and/or at increased risk of fracture, will be randomized to receive either teriparatide or zoledronic acid. Trabecular microarchitecture, biomechanical parameters and bone mineral density will be examined at 0 and 12 months at 3T MRI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01153425
Study type Interventional
Source University of Pennsylvania
Contact
Status Completed
Phase Phase 4
Start date July 2008
Completion date December 2012

See also
  Status Clinical Trial Phase
Completed NCT03413540 - Effects of Jumping on Bone Health in Young Women N/A
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Recruiting NCT01844154 - Fracture and Fall Prevention in Elderly With Osteoporosis N/A
Completed NCT04169698 - Alendronate Versus Denosumab in Kidney Transplant Patients Phase 2/Phase 3
Completed NCT03408119 - Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men N/A
Completed NCT00330096 - Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women Phase 3
Recruiting NCT06305156 - Protocol Optimization in CT for the Quantification of BMD N/A
Completed NCT03026660 - Moringa Oleifera on Bone Density N/A
Completed NCT04748250 - Effect of Soy Phytoestrogens and Acupuncture on Bone Mineral Density in Female Athlete Triad at Adolescence Age N/A
Not yet recruiting NCT03518268 - Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor Phase 1/Phase 2
Completed NCT04535180 - Sarcopenia and Osteoporosis in the Patients With Hemophilia
Recruiting NCT05712252 - Risk Factors for Fall and Fracture
Completed NCT03367585 - Effects of Vitamin D Supplementation in Muscle Strength and Balance Training N/A
Completed NCT03091088 - Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women N/A
Recruiting NCT06279078 - Long-term Effect of Steroid on Metabolic Diseases in Asthmatics
Completed NCT04526327 - Osteosarcopenia and Exercise N/A
Recruiting NCT03467035 - Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis N/A
Not yet recruiting NCT04034199 - Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid Phase 3
Completed NCT06359353 - Effect of Pitavastatin on Bone Phase 4
Completed NCT03898024 - Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass N/A